Hi everyone, I have made a test yesterday. On a G
Post# of 36537
(Total Views: 304)
Posted On: 04/16/2020 1:02:56 PM
Hi everyone,
I have made a test yesterday. On a German Investor - platform, I have seen a news feed from an investment newsletter called "smart investor", which published an article about several biotech companies, who are currently involved in any kind of Covid-19 related development, be it quick test kits, vaccine or medication development. Sort of mainstream bla bla.
However, I wanted to find out if the author ever heard of GNBT and if yes, what he thinks of GNBT and why they have not included them in their article. Just to make sure, I included a link to GNBT 's latest PR and even summarized the most important facts from it.
This afternoon I received a very short, 4 line answer from them, where the chief editor wrote, that they do not like this stock, called it a typical pusher-paper, pointed at the roller coaster share price moves and judged it to be worth nothing more than good for a quick gamble, but did not see any value in it at all.
From this short response, I am almost 100% certain, that even such a professional, admitted the smartest of him was most likely the title of his news letter, LOL, had obviously never heard of GNBT or NGIO before. He then spent 2 minutes to check it out, and came up with such a devastating judgement.
I am sure, this has to change in general! And in particular, such easy BS judgements have to stop! Or otherwise GNBT will have even more difficulties to ever get out of the current pps range.
I have made a test yesterday. On a German Investor - platform, I have seen a news feed from an investment newsletter called "smart investor", which published an article about several biotech companies, who are currently involved in any kind of Covid-19 related development, be it quick test kits, vaccine or medication development. Sort of mainstream bla bla.
However, I wanted to find out if the author ever heard of GNBT and if yes, what he thinks of GNBT and why they have not included them in their article. Just to make sure, I included a link to GNBT 's latest PR and even summarized the most important facts from it.
This afternoon I received a very short, 4 line answer from them, where the chief editor wrote, that they do not like this stock, called it a typical pusher-paper, pointed at the roller coaster share price moves and judged it to be worth nothing more than good for a quick gamble, but did not see any value in it at all.
From this short response, I am almost 100% certain, that even such a professional, admitted the smartest of him was most likely the title of his news letter, LOL, had obviously never heard of GNBT or NGIO before. He then spent 2 minutes to check it out, and came up with such a devastating judgement.
I am sure, this has to change in general! And in particular, such easy BS judgements have to stop! Or otherwise GNBT will have even more difficulties to ever get out of the current pps range.
(5)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼